TABLE 1

Clinical Protocol and Characteristics

Protocol	Type	Patient population	Description
2728	Phase I/II	B-NHL, T-NHL, HL	⁹⁰Y-DOTA-BC8, BEAM chemotherapy, autologous peripheral blood stem cell transplantation
2450	Phase I	Multiple myeloma	⁹⁰Y-DOTA-BC8, fludarabine, TBI, HLA-matched blood stem cell transplantation
2468	Phase I	AML, ALL, MDS	⁹⁰Y-DOTA-BC8, fludarabine, TBI (2 Gy), allogeneic stem cell transplantation
2361	Phase I	B-NHL, T-NHL, or HL	⁹⁰Y-DOTA-BC8, autologous peripheral blood stem cell transplantation

B-NHL = B-cell non-Hodgkin’s lymphoma; T-NHL = T-cell non-Hodgkin’s lymphoma; HL = Hodgkin’s lymphoma; BEAM = carmustine, etoposide, cytarabine, and melphalan; TBI = total-body irradiation; HLA = human leukocyte antigen; AML = acute myeloid leukemia; ALL = acute lymphoblastic leukemia.